1. Home
  2. RVSB vs CRDL Comparison

RVSB vs CRDL Comparison

Compare RVSB & CRDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVSB
  • CRDL
  • Stock Information
  • Founded
  • RVSB 1923
  • CRDL 2017
  • Country
  • RVSB United States
  • CRDL Canada
  • Employees
  • RVSB N/A
  • CRDL N/A
  • Industry
  • RVSB Savings Institutions
  • CRDL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • RVSB Finance
  • CRDL Health Care
  • Exchange
  • RVSB Nasdaq
  • CRDL Nasdaq
  • Market Cap
  • RVSB 122.2M
  • CRDL 102.0M
  • IPO Year
  • RVSB 1993
  • CRDL N/A
  • Fundamental
  • Price
  • RVSB $5.14
  • CRDL $1.20
  • Analyst Decision
  • RVSB
  • CRDL Strong Buy
  • Analyst Count
  • RVSB 0
  • CRDL 3
  • Target Price
  • RVSB N/A
  • CRDL $9.00
  • AVG Volume (30 Days)
  • RVSB 34.8K
  • CRDL 265.5K
  • Earning Date
  • RVSB 01-30-2025
  • CRDL 03-31-2025
  • Dividend Yield
  • RVSB 1.54%
  • CRDL N/A
  • EPS Growth
  • RVSB N/A
  • CRDL N/A
  • EPS
  • RVSB 0.04
  • CRDL N/A
  • Revenue
  • RVSB $46,646,000.00
  • CRDL N/A
  • Revenue This Year
  • RVSB N/A
  • CRDL N/A
  • Revenue Next Year
  • RVSB $13.88
  • CRDL N/A
  • P/E Ratio
  • RVSB $139.08
  • CRDL N/A
  • Revenue Growth
  • RVSB N/A
  • CRDL N/A
  • 52 Week Low
  • RVSB $3.30
  • CRDL $1.15
  • 52 Week High
  • RVSB $5.89
  • CRDL $3.12
  • Technical
  • Relative Strength Index (RSI)
  • RVSB 20.43
  • CRDL 41.60
  • Support Level
  • RVSB $5.30
  • CRDL $1.15
  • Resistance Level
  • RVSB $5.48
  • CRDL $1.51
  • Average True Range (ATR)
  • RVSB 0.10
  • CRDL 0.10
  • MACD
  • RVSB -0.04
  • CRDL -0.01
  • Stochastic Oscillator
  • RVSB 0.00
  • CRDL 13.65

About RVSB Riverview Bancorp Inc

Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's lead product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.

Share on Social Networks: